- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 417/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Patent holdings for IPC class C07D 417/12
Total number of patents in this class: 6991
10-year publication summary
|
565
|
514
|
461
|
529
|
494
|
505
|
413
|
423
|
463
|
129
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
187 |
| F. Hoffmann-La Roche AG | 7958 |
111 |
| Boehringer Ingelheim International GmbH | 4629 |
103 |
| Novartis AG | 11238 |
102 |
| Merck Sharp & Dohme LLC | 3689 |
99 |
| AstraZeneca AB | 3042 |
95 |
| Janssen Pharmaceutica N.V. | 3839 |
94 |
| BASF SE | 19740 |
93 |
| Takeda Pharmaceutical Company Limited | 2961 |
75 |
| Shionogi & Co., Ltd. | 914 |
71 |
| Vertex Pharmaceuticals Incorporated | 1581 |
70 |
| Syngenta Participations AG | 4970 |
68 |
| Amgen Inc. | 3779 |
68 |
| Bayer Cropscience AG | 2241 |
55 |
| Hoffmann-La Roche Inc. | 3060 |
53 |
| Astellas Pharma Inc. | 1145 |
46 |
| Abbvie Inc. | 1808 |
45 |
| Gilead Sciences, Inc. | 1879 |
45 |
| The Regents of the University of California | 18943 |
44 |
| Allergan, Inc. | 2600 |
40 |
| Other owners | 5427 |